Matthew K. Szot - Chief Financial Officer at Cadrenal Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Issuer Symbol
CVKD on Nasdaq
All Insider Reports
All Insider Reports

Matthew K. Szot - trading volume in the past year for Cadrenal Therapeutics, Inc.

Holdings reported by Matthew K. Szot for Cadrenal Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $6.97 29 Dec 2025 Direct
Stock Options 50,000 23 Jan 2025 Direct Common Stock

Transactions reported by Matthew K. Szot for Cadrenal Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.